In a patient with asthma, a clear chest examination, and a hemoglobin of 10 g/dL who is scheduled for bilateral knee replacement, how should the anesthesia be planned?

Anesthesia Planning for Bilateral Knee Replacement in an Asthmatic Patient with Anemia

For this asthmatic patient with Hb 10 g/dL undergoing bilateral knee replacement, I recommend spinal anesthesia with intrathecal morphine combined with femoral nerve block, avoiding general anesthesia if possible to minimize bronchospasm risk. 1

Preoperative Optimization

Asthma Management

Your patient's clear chest is reassuring, but preoperative bronchodilator administration is essential. Asthmatic patients must receive bronchodilator premedication before any anesthetic procedure 2. This reduces the 8% risk of laryngospasm or bronchospasm that can occur even in well-controlled asthmatics 2.

• Administer inhaled bronchodilator (albuterol/salbutamol) 30-60 minutes preoperatively
• Consider adding anticholinergic (ipratropium) if patient has moderate-severe asthma history
• Ensure patient continues their regular inhaled corticosteroid regimen through the perioperative period 3, 4

Anemia Considerations

The Hb of 10 g/dL is below normal but generally acceptable for elective orthopedic surgery. While some studies show acceptable perioperative outcomes with Hb ≥7 g/dL 5, bilateral knee replacement involves significant blood loss potential. This hemoglobin level does not require preoperative transfusion but warrants careful intraoperative monitoring and lower threshold for transfusion 6.

• Establish large-bore IV access before induction
• Type and crossmatch blood (anticipate 2-4 units for bilateral procedure)
• Consider tranexamic acid to minimize blood loss
• Monitor oxygen saturation continuously—anemia reduces oxygen reserve 5

Anesthetic Technique Selection

Primary Recommendation: Spinal Anesthesia

Spinal anesthesia with intrathecal morphine is the preferred technique for knee arthroplasty in asthmatic patients 1. This approach:

• Eliminates airway manipulation and bronchospasm triggers
• Provides excellent postoperative analgesia (reducing opioid requirements)
• Avoids general anesthetic agents that may precipitate bronchospasm
• Maintains spontaneous ventilation

Technical details:

• Spinal local anesthetic (bupivacaine 12-15 mg) + morphine 100-200 mcg
• Add femoral nerve block (single-injection or continuous catheter) for supplemental analgesia 1
• Sedation should be minimal and carefully titrated given asthma history 2

If General Anesthesia is Required

Should regional anesthesia be contraindicated or refused, follow this approach:

Induction agents:

• Propofol is preferred—it inhibits bronchoconstriction and causes central airway dilation 7
• Ketamine is an excellent alternative—provides bronchodilation through sympathomimetic activity, though increases secretions (manageable with glycopyrrolate) 8, 7
• Avoid thiopental—can cause severe bronchoconstriction in asthmatics with cholinergic stimulation 8

Airway management:

• Laryngeal mask airway (LMA) is safer than endotracheal intubation in asthmatics 7
• If intubation necessary: use lidocaine 1.5 mg/kg IV 90 seconds before intubation to blunt airway reflexes 7
• Ensure adequate depth before airway manipulation

Maintenance:

• Volatile agents (sevoflurane, desflurane, isoflurane) are potent bronchodilators 9, 7
• Desflurane provides faster emergence in patients with reduced oxygen reserve 9

Neuromuscular blockade:

• Use rocuronium, vecuronium, or cisatracurium—these do not release histamine 7
• Avoid atracurium and mivacurium—dose-dependent histamine release can trigger bronchospasm 7
• Monitor neuromuscular blockade quantitatively; ensure TOF >90% before extubation 10

Intraoperative Management

• Continuous pulse oximetry is mandatory 2—maintain SpO2 ≥90% throughout
• Supplemental oxygen to compensate for reduced oxygen-carrying capacity
• Avoid hypothermia (worsens oxygen delivery)
• Liberal fluid administration for bilateral procedure, but monitor for volume overload given anemia
• Have bronchodilators immediately available (albuterol inhaler, IV magnesium sulfate, IV aminophylline)

Postoperative Care

Analgesia Strategy

Multimodal opioid-sparing analgesia is critical 9, 1:

• Continue femoral nerve block/catheter for 48-72 hours
• Scheduled acetaminophen 1g q6h
• NSAIDs (if no contraindications)
• Minimize systemic opioids—they increase respiratory depression risk in asthmatics 9

Monitoring

• Extended PACU observation with continuous oximetry
• Monitor for bronchospasm during emergence (high-risk period) 9, 11
• Maintain head-up position throughout recovery 9
• Early mobilization essential despite bilateral procedure 9

Respiratory Management

• Continue bronchodilators postoperatively
• Incentive spirometry to prevent atelectasis
• Supplemental oxygen as needed to maintain SpO2 ≥92%

Critical Pitfalls to Avoid

1. Do not withhold bronchodilators perioperatively—continue all asthma medications
2. Avoid histamine-releasing drugs (morphine, atracurium, mivacurium)
3. Do not use excessive sedation—increases bronchospasm risk and respiratory depression 2
4. Avoid extubation under light anesthesia—ensure patient fully awake if intubated 10
5. Do not ignore the anemia—have low threshold for transfusion if Hb drops below 8 g/dL intraoperatively

Emergency Bronchospasm Management

If bronchospasm occurs despite precautions 11:

• 100% oxygen
• Deepen anesthesia with volatile agent or propofol
• Albuterol via MDI (6-8 puffs) or nebulizer
• Consider IV magnesium sulfate 2g over 20 minutes
• IV aminophylline if refractory
• Epinephrine 50 mcg IV boluses for severe bronchospasm